All Scottish Enterprise articles
-
NewsNexaBiome accelerates development of novel diabetic foot treatment with Scottish Enterprise funding
UK biotechnology company NexaBiome Life Sciences Ltd has received continued funding from Scotland’s national economic development agency, Scottish Enterprise, to accelerate its breakthrough bacteriophage technology for the treatment of diabetic foot infections (DFIs).
-
NewsMicroplate DX secures £2.5m to develop rapid diagnostic technology that confirms presence of bacteria
Microplate Dx has closed a £2.5M seed funding round to develop its point-of-care diagnostic platform which can guide a patient’s doctor to effective treatment by identifying effective antibiotics to use and which to avoid.